Roche Venture Fund
VC
INVESTOR TYPE
Active
STATUS
5
PROFESSIONALS
125
INVESTMENTS
33
PORTFOLIO
62
EXITS
Description
The Roche Venture Fund is the corporate venture capital arm of Roche Holding. It specializes in growth capital and early stage investments. The firm prefers to invest in life sciences, pharmaceuticals, diagnostics equipment and healthcare sectors. The firm was founded in 2002 and is based in Basel, Switzerland.
Investor Status
Actively Seeking New Investments
Year Founded
2002
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- Grenzacherstrasse 124
- 4070 Basel
- Switzerland
+41 061 000 00 00
Roche Venture Fund Investments (125)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Freenome | 24-Jul-2019 | Early Stage VC | 00000 | Biotechnology | Generating Revenue | |
| 0000000 0000000000 | 12-Jun-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000000 0000 00.0 |
| 0000 00000000 | 25-Mar-2019 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 000000 000000000000 00 |
| 000000000 | 04-Mar-2019 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | 000000 000000000000 00 |
| 0000 000000000000 | 31-Jan-2019 | 00000 00000 | 000.00 | Drug Discovery | Startup | 0000 0000000000 |
| 0000000 0000000000 | 26-Sep-2018 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 00000000 00.0 |
| 0000000 | 10-Sep-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000000 0000 00.0 |
| 000000 00000000000 | 26-Aug-2018 | 00000 00000 | 00.000 | Drug Discovery | Bankruptcy: Liquidation | |
| Care Innovations | 18-Jun-2018 | Later Stage VC | 000.00 | Other Healthcare Services | Generating Revenue | |
| SutroVax | 19-May-2018 | Later Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 0000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Roche Venture Fund’s full profile, request a free trial.
Roche Venture Fund Exits (62)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| IDEAYA Biosciences | 23-May-2019 | IPO | 0000 | Completed |
|
| 000000 00000000000 | 13-Jan-2019 | 0000000000: 000000 | Completed |
|
|
| 0000000 | 31-Jul-2018 | 000000000000000000 | 00000 | Completed |
|
| 0000000 | 19-Jul-2018 | 000 | 00000 | Completed |
|
| 00000000 | 06-Apr-2018 | 000000000000000000 | 00.00 | Completed |
|
| 0000000 | 17-Nov-2017 | 000000000000000000 | Completed |
|
|
| 000000 | 30-Jun-2017 | 000000000000000000 | 00000 | Completed |
|
| 0000000 0000000000 | 29-Jun-2017 | 000 | 000.00 | Completed |
|
| CytomX Therapeutics | 31-Mar-2017 | Secondary Transaction - Open Market | Completed |
|
|
| AveXis | 16-Mar-2017 | Secondary Transaction - Open Market | Completed |
|
Roche Venture Fund Team (11)
5 Former Team Members
You’re viewing 5 of 11 team members. Get the full list »Roche Venture Fund Co-Investors (178)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| 5AM Ventures | 5 | 0 | |
| SR One | 0 | 0 | |
| Pfizer Ventures | 0 | 0 | |
| New Enterprise Associates | 0 | 0 | |
| T. Rowe Price | 0 | 0 | 0 |